News & analysis on the clinical development and manufacture of large molecule drugs
Dispatches from Korea
Inside Celltrion: a biosimilar success story built on landfill
By Dan Stanton
- Last updated on
Biopharma-Reporter visited the 'pioneers of the mAb biosimilar industry'
Ambition, hard work and a focus on quality has made Celltrion the ‘pioneers of the mAb biosimilar industry,’ the firm told Biopharma-Reporter during a tour of its biomanufacturing site in Songdo, Korea.